EyePoint Pharmaceuticals
EYPT
$19.74
Share price
-1.00%
Change (1 day)
201.83%
Change (1 year)
Categories
EyePoint Pharmaceuticals (EYPT) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $88.86 M
According to EyePoint Pharmaceuticals 's latest financial reports the company's total liabilities are $88.86 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
EyePoint Pharmaceuticals - Total liabilities on balance sheet (from 2003 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $88.86 M | 5.8% |
| 2022-12-31 | $83.98 M | 6.32% |
| 2021-12-31 | $78.99 M | 7.95% |
| 2020-12-31 | $73.17 M | 13.2% |
| 2019-12-31 | $64.64 M | |
| 2018-06-30 | $59.98 M | 1023.07% |
| 2017-06-30 | $5.34 M | -50.26% |
| 2016-06-30 | $10.73 M | 19.32% |
| 2015-06-30 | $8.99 M | 16.16% |
| 2014-06-30 | $7.74 M | -9.38% |
| 2013-06-30 | $8.54 M | 22.81% |
| 2012-06-30 | $6.96 M | -28.09% |
| 2011-06-30 | $9.68 M | -2.94% |
| 2010-06-30 | $9.97 M | -26.47% |
| 2009-06-30 | $13.56 M | -47.24% |
| 2008-06-30 | $25.7 M | 35.61% |
| 2007-06-30 | $18.95 M | -57.77% |
| 2006-06-30 | $44.88 M | 385.67% |
| 2005-06-30 | $9.24 M | 586.23% |
| 2004-06-30 | $1.34 M | 128.9% |
| 2003-06-30 | $0.58 M | |
| 2001-06-30 | $0.14 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | $3.14 M | -96.46% | Bahamas |
 NRC Health
NRC | $73.48 M | -17.31% | 🇺🇸 USA |